Kymera Therapeutics Inc (KYMR)
Kymera Therapeutics Market Cap: 2.144B for May 17, 2024
Market Cap Chart
Historical Market Cap Data
Date | Value |
---|---|
May 17, 2024 | 2.144B |
May 16, 2024 | 2.184B |
May 15, 2024 | 2.205B |
May 14, 2024 | 2.153B |
May 13, 2024 | 2.354B |
May 10, 2024 | 2.325B |
May 09, 2024 | 2.369B |
May 08, 2024 | 2.362B |
May 07, 2024 | 2.359B |
May 06, 2024 | 2.350B |
May 03, 2024 | 2.295B |
May 02, 2024 | 2.227B |
May 01, 2024 | 2.224B |
April 30, 2024 | 2.063B |
April 29, 2024 | 2.127B |
April 26, 2024 | 2.048B |
April 25, 2024 | 2.046B |
April 24, 2024 | 2.160B |
April 23, 2024 | 2.191B |
April 22, 2024 | 2.108B |
April 19, 2024 | 2.084B |
April 18, 2024 | 2.155B |
April 17, 2024 | 2.071B |
April 16, 2024 | 2.082B |
April 15, 2024 | 2.110B |
Date | Value |
---|---|
April 12, 2024 | 2.183B |
April 11, 2024 | 2.283B |
April 10, 2024 | 2.168B |
April 09, 2024 | 2.307B |
April 08, 2024 | 2.231B |
April 05, 2024 | 2.233B |
April 04, 2024 | 2.223B |
April 03, 2024 | 2.278B |
April 02, 2024 | 2.309B |
April 01, 2024 | 2.419B |
March 28, 2024 | 2.457B |
March 27, 2024 | 2.455B |
March 26, 2024 | 2.413B |
March 25, 2024 | 2.414B |
March 22, 2024 | 2.488B |
March 21, 2024 | 2.495B |
March 20, 2024 | 2.465B |
March 19, 2024 | 2.418B |
March 18, 2024 | 2.403B |
March 15, 2024 | 2.480B |
March 14, 2024 | 2.415B |
March 13, 2024 | 2.585B |
March 12, 2024 | 2.558B |
March 11, 2024 | 2.584B |
March 08, 2024 | 2.658B |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
Market Cap Benchmarks
Immunic Inc | 112.15M |
Insmed Inc | 3.681B |
SELLAS Life Sciences Group Inc | 84.32M |
Iovance Biotherapeutics Inc | 2.865B |
Intellia Therapeutics Inc | 2.530B |
Market Cap Related Metrics
PS Ratio | 27.07 |
Price to Book Value | 3.015 |
Price | 34.94 |
Earnings Yield | -7.18% |